Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

withdrawn267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminated

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

NCT03706430
withdrawnnot_applicable

Monitoring Noninvasively for Infusion and Transfusion Optimization

NCT04388722
withdrawnnot_applicable

Pleth Variability Index (PVI) to Predict Fluid Responsiveness

NCT03120910

Clinical Trials (3)

Showing 3 of 3 trials
NCT03706430

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

Terminated
NCT04388722Not Applicable

Monitoring Noninvasively for Infusion and Transfusion Optimization

Withdrawn
NCT03120910Not Applicable

Pleth Variability Index (PVI) to Predict Fluid Responsiveness

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3